276173
Comparison of quitline vs. web-based tobacco cessation interventions in four states, implications for publicly-funded tobacco cessation services
Tuesday, November 5, 2013
Antonio Neri, MD, MPH
,
Division of Cancer Prevention and Control, Centers for Disease Control and Preventions, Chamblee, GA
Behnoosh Momin, MS, MPH
,
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Chamblee, GA
Jennifer Duke, PhD
,
RTI International, Boulder, CO
Kristen L. McCausland, MPH, MSW
,
Brown University, Providence, RI
Heather Hansen, MPP
,
Public Health Policy Program, RTI International, Washington, DC
Paul Shafer, MS
,
Public Health Policy Research Program, RTI International, Research Triangle Park, NC
Vance Rabius, PhD
,
University of Texas, MD Anderson Cancer Center, Houston, TX
Lei Zhang, PhD
,
Office on Smoking and Health, Centers for Disease Control and Prevention, Chamblee, GA
Jennifer W. Kahende, PhD
,
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion / Office on Smoking and Health, Atlanta, GA
Sherri L. Stewart, PhD
,
National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, CCCB, Centers for Disease Control and Prevention (CDC), Atlanta, GA
Tobacco use is increasing in spite of sufficient evidence that it causes ten types of cancer, and suggestive evidence of a causal relationship to others. Tobacco quitlines are a common approach for cessation while Web-based modalities are increasingly prevalent. The reach, user population, and effectiveness of each approach vary considerably. Large studies comparing these modalities focus on healthcare plan based cessation programs or are limited to one state. It is difficult to apply the results from these studies to state-based cessation programs. The Centers for Disease Control and Prevention collected intake and 7-month follow-up information from tobacco cessation program users in 4 states. Participants were enrolled through either a state-hosted quitline or website throughout 2011 and 2012. The primary outcome measure was prevalence of 30-day abstinence (30-day AP) at follow-up. Investigators recruited 2,724 quitline and 2,561 Web-based users. A majority of study participants were female (61%) and white, non-Hispanic (79%). The 30-day AP was 32% for quitline and 27% for Web-based users. Web-based users were significantly more likely to be younger ( 40 yrs vs. 47 yrs), employed (62% vs. 37%), and partnered (52% vs. 40%) than quitline users. Among participants with two or more interactions in either modality, quitline participants had 1.37 the odds (95% Cl 1.09–1.72) of 30-day abstinence at 7-month follow-up versus Web-based users. Further analyses of the cost-effectiveness of each approach are underway. These results will help public health agencies focus their tobacco and cancer control interventions.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practice
Epidemiology
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Program planning
Public health administration or related administration
Learning Objectives:
Describe the demographic, behavioral, and success of quitline and Web-based tobacco cessation activities in state health departments.
Compare the effectiveness of quitline and Web-based tobacco cessation approaches as they apply to government public health agencies.
Identify effective quitline and Web-based tobacco cessation approaches that could be used or improved upon in your country, state, tribe, territory, or local jurisdiction.
Keywords: Evidence Based Practice, Tobacco Control
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I co-led the study and was responsible for directing the study design, implementation, analysis, and reporting of results.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.